Meta-Iodobenzylguanidine-131I (MIBG-131I) for therapeutic use, solution for injection

Radionuclidic purity: 

≥ 99.9%

Radiochemical purity: 

≥ 92%


24 hours


4 days from the manufacturing date (expiry date is stated on the label).


Store MIBG-131I in an original container at the temperature below [-15oC], in accordance with regulations for radiation safety.  Transport in dry ice.
Protect from light. After defrosting store below 25oC for up to 2 hours. Transport in dry ice.

Pharmaceutical form: 

Solution for injection.

Active substance: 

Meta-Iodo[131I]benzylguanidine sulphate,   370 - 740 MBq/ml


sodium metabisulphite
copper (II) sulphate pentahydrate
sodium acetate trihydrate
acetic acid
benzyl alcohol
sodium chloride
water for injection


The MIBG-131I solution is delivered in 10 ml glass vials, with a possibility of drawing multidoses in an aseptic way. The vials are capped with rubber stoppers and aluminum caps and placed inside a shielded lead container. The outer transport packaging is a metal tin  with styrofoam insert.
Every source is accompanied with a certificate of radioactivity.


Meta-Iodobenzylguanidine-131I (MIBG-131I) is a radiopharmaceutical used in cancer therapy. It is used in treating disseminated, malignant, metastatic lesions, such as pheochromocytoma, paraganglioma, neuroblastoma, neuroendocrine tumors of gestroenteropancreatic tract, and sometimes medullary thyroid carcinoma.




Our product range includes radiopharmaceuticals, radiochemicals, radioactivity standards and sealed radiation sources. We offer a broad selection of services and workshops, and training.

About Us

National Centre for Nuclear Research, Radioisotope Centre POLATOM is manufacturer and distributor of the isotopic goods applied in medicine, research and development, industry and environment protection.


The high professionalism of our company has been confirmed by a number of certificates including GMP for radiopharmaceutical production.